SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Trade/Invest with Options Jerry a Point & Figure Chartist

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GREENLAW4-7 who wrote (3846)10/1/2001 8:36:32 AM
From: Jerry Olson  Read Replies (1) of 5893
 
Live Headline
01-Oct-01
08:35 ET Millennium Pharm (MLNM) 17.76: First Union Securities out with positive comments following Friday's Phase II trial results on Campath reported by Millennium's marketing partner, Schering AG; the firm has a Strong Buy rating on MLNM with a $42 price target.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext